-
Taxonomy & unit
-
dei: USD
-
Description
-
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
-
Summary
-
Nurix Therapeutics, Inc. quarterly Entity Public Float history and change rate from Q2 2020 to Q2 2024.
- Nurix Therapeutics, Inc. Entity Public Float for the quarter ending 31 May 2024 was $996M, a 112% increase year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)